Targeted Sanger Sequencing is the gold-standard technique for reading the exact DNA sequence of a specific gene or region of interest. First developed in 1977 and still the most trusted method for confirming genetic variants, Sanger sequencing uses dideoxy chain termination to produce highly accurate, base-by-base sequence reads of targeted DNA regions. It is the method of choice for confirming variants identified by NGS testing, sequencing known hotspot mutations in a specific gene, validating family member carrier status for a known familial variant, and providing definitive diagnosis when a specific genetic cause is strongly suspected.
Base-by-base sequence read of the targeted gene region — the most accurate way to read a specific DNA segment
Confirms or rules out a specific variant previously identified by NGS testing — eliminates false positives
Pathogenic, likely pathogenic, VUS, or benign — clinically actionable classification of the identified variant
Rapid, affordable testing of parents, siblings, or children for a known familial variant
Electropherogram trace + written report with variant interpretation — ready for medical records and specialist review
Most affordable clinical sequencing option — targeted approach means lower cost than broad panel testing
Place your order and mention the gene or variant to be sequenced — include your doctor's referral or previous NGS report so our team can design the right primers.
2–3ml EDTA blood at home or nearby lab. Return with prepaid courier label included in your kit.
Target region amplified by PCR using gene-specific primers, then sequenced using Sanger dideoxy chain termination chemistry on an ABI capillary sequencer in our NABL & CAP lab.
Sequencing results analyzed by our molecular geneticist — colored peak electropherogram reviewed base-by-base and variant classified per ACMG guidelines.
Comprehensive report including electropherogram trace, variant classification, clinical significance, and recommendation for family testing if applicable.
A snapshot of your single-gene variant confirmation report
Before or after Targeted Sanger Sequencing
If the causative gene is unknown, WES sequences all 23,000 protein-coding genes to identify the variant — then Sanger confirms it. The discovery step before targeted confirmation.
When large deletions or duplications are suspected rather than point mutations — CMA detects copy number variants that Sanger cannot identify.
For comprehensive BRCA analysis — full gene NGS sequencing of both BRCA1 and BRCA2 rather than targeted single-variant Sanger confirmation.